ARTICLE | Company News
RXi, Iovance Biotherapeutics combining technologies to treat solid tumors
June 8, 2018 3:24 PM UTC
RXi Pharmaceuticals Corp. (NASDAQ:RXII) and Iovance Biotherapeutics (NASDAQ:IOVA) will evaluate combining RXi's self-delivering RNAi technology with Iovance's Tumor Infiltrating Lymphocytes (TILs) in ...